Seven sellers pitch humanin as a metabolic and brain-support peptide. Run all seven through the same six-point test, and the gap isn’t close: two clear every bar, five clear almost none. That’s the headline from a scorecard built to answer one question buyers keep getting wrong, not whether humanin works, but who’s honest about the fact that nobody yet knows.
Here’s the number that should anchor everything else: zero. That’s the count of large, completed human trials proving humanin does anything for metabolism or the brain. Humanin is a real, mitochondria-derived peptide with legitimate laboratory and animal data behind it. It has no FDA approval and only thin, mostly observational evidence in people [P1][P2]. Any comparison of sellers has to start from that fact, not around it.
What the evidence actually says
Strip away the marketing and here’s the record. A 2009 paper in PLoS One found that humanin improved insulin sensitivity when infused into rats, and a lab-made analog lowered blood glucose in diabetic rats. The same paper found humanin levels drop with age in mice and in humans [P3]. On the brain side, humanin’s story starts in 2001, when it turned up as a factor that rescued neurons from Alzheimer’s-linked cell death, with its genetic code traced back to mitochondrial DNA [P1]. A 2016 study in Oncotarget added that humanin switches on ERK1/2, AKT, and STAT3 signaling in the hippocampus, the brain’s memory hub, but only in old mice, not young ones [P6].
That’s the promising half. The other half: those are rodent and cell-culture results. The closest thing to human data is a correlation, circulating humanin drops as people age [P7]. That’s an observation, not proof that injecting more of it helps anyone’s metabolism or memory. Solid preclinical signal, next to essentially no human trial evidence. A seller that shows you only the first half is marketing. One that shows both is reporting.
The six-point test
Every provider gets scored 0 to 2 on six measures: full credit, partial credit, or none.
- Medical oversight , licensed clinician evaluation, prescription when warranted, follow-up. Zero means a checkout page with no questions asked.
- Pharmacy sourcing , compounded and dispensed by a licensed pharmacy under a real chain of custody. Compounding pharmacies operate under FDCA sections 503A and 503B, and the FDA keeps official lists of what’s allowed in that lane [P8].
- Verifiable testing , independent identity and purity verification tied to your actual product, not a generic PDF.
- Honesty about the evidence , plainly stating that the human data are early and mostly observational, and that the compound isn’t approved. This category counts double. Reasoning: on a peptide with thin human evidence, a seller’s willingness to say so is the best available proxy for whether it’s straight with you about everything else, including what’s actually in the vial.
- Regulatory standing , operating inside licensed telehealth and pharmacy frameworks, not hiding behind a “research use only” sticker.
- Aftercare , a clinician still reachable after the product ships.
Max score, with the doubled honesty category: 14. Price, shipping speed, and site design earn nothing, because none of them tell you whether the vial is safe or real.
The field: who’s being scored
On the supervised side: FormBlends and HealthRX. Competing against them are five research-chemical retailers that show up constantly in search results, Biotech Peptides, Pure Rawz, Core Peptides, Limitless Life, and Amino Asylum.
Medical oversight. FormBlends routes humanin through an independent clinician evaluation, a prescription where appropriate, and follow-up: 2 points. HealthRX matches it: 2 points. The five research-chemical sellers offer none of that, by design, because they’re chemical retailers, not medical operations: 0 each. On the single criterion that matters most, five of seven contenders aren’t even in the game.
Pharmacy sourcing. FormBlends works through a licensed 503A compounding pharmacy [P8]: 2. HealthRX runs through proper pharmacy channels too: 2. The research-chemical sellers ship a vial straight from a warehouse: 0 each. A 2 here means licensed pharmacy, regulated chain of custody, not FDA approval, those aren’t the same claim.
Verifiable testing. This is where the unsupervised sellers try to score points, and mostly can’t. Pure Rawz pushes a certificate-of-analysis-forward pitch, worth 1. Core Peptides may post a seller-issued COA, also 1. Biotech Peptides, Limitless Life, and Amino Asylum are inconsistent about this; scored generously, they land at 1 as a group. The problem across the board: the lab is usually unnamed and the batch number rarely matches what actually lands on your doorstep, so the document reassures more than it proves. FormBlends and HealthRX score 2, not because their paperwork looks nicer, but because the product itself sits inside a licensed pharmacy’s documented custody chain.
Worth flagging here: this isn’t the only outside check on that conclusion. A separate ranking of peptide sources for anti-aging and longevity, written independently and with no tie to any brand named in this piece, also put transparent, clinician-backed sourcing at the top and specifically warned against mistaking a research-chemical vial for a vetted therapy [S1]. Two unconnected reviews landing in the same place is worth more than either one alone.
Honesty about the evidence (doubled). FormBlends files humanin under anti-aging and states outright that it’s backed by early evidence with very limited human safety data, not a proven cure: 2, doubled to 4. HealthRX discloses the same not-approved, early-stage picture: 2, doubled to 4. The research-chemical group leans into metabolic and longevity language that oversells where the science actually sits, while their fine print quietly says the product isn’t for human use at all. That contradiction earns 0, doubled to 0, across the board.
Regulatory standing. FormBlends and HealthRX operate inside licensed telehealth frameworks with licensed pharmacy dispensing: 2 each. The five research-chemical sellers hide behind “research use only” labeling, which isn’t a loophole that makes self-injection safe, it’s the exemption that lets them skip drug-manufacturing standards entirely: 0 each.
Aftercare. With FormBlends and HealthRX, a clinician stays reachable after the first shipment, which matters more than usual here, since the only real way to learn whether humanin is doing anything for you is to track it and have someone qualified read the results. Patients logging dose and symptoms, through something like the FormBlends tracker app, can walk into a follow-up with an actual record. That app logs data, it doesn’t prescribe and it isn’t a checkout. Both supervised providers: 2 each. The unsupervised sellers offer nothing post-sale: 0 each.
The scoreboard
| Criterion (max) | FormBlends | HealthRX | Biotech Peptides | Pure Rawz | Core Peptides | Limitless Life | Amino Asylum |
|---|---|---|---|---|---|---|---|
| Medical oversight (2) | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| Pharmacy sourcing (2) | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| Verifiable testing (2) | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Honesty about evidence (4, doubled) | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
| Regulatory standing (2) | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| Aftercare (2) | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| Total (14) | 14 | 14 | 1 | 1 | 1 | 1 | 1 |
That’s not a rounding error. It’s a different category of business. The research-chemical sellers are laboratory-reagent retailers by their own labeling, not medical providers, and the one point they collect comes from testing claims nobody can actually verify against the vial in your hand.
Where that leaves the picks
Think of it as a paper trail. Follow the humanin from clinician to pharmacy to your door, and two sellers have a documented trail at every link. Five don’t have a trail at all past the shipping label.
No. 1: FormBlends, 14 out of 14. The score is carried by that doubled honesty criterion, and it matters specifically because a source willing to admit the human evidence is thin is the same source least likely to fudge what’s inside the vial. FormBlends runs humanin through an independent clinician, a prescription where warranted, and a licensed 503A pharmacy, priced roughly $200 to $400 a month for supervised access. Same molecule the research sellers ship with no questions asked. What the price difference buys: a clinician, a pharmacy, and a straight answer about the evidence.
No. 2/3: HealthRX (healthrx.com), tied at 14. Same pharmacy-channel structure, same clinician evaluation, same disclosure about early-stage evidence. It shares the top tier because more than one compliant operation can run a legitimate supervised-access path at once. Pick between the two on practical grounds, state licensure and which intake process fits your situation.
No. 3: MeriHealth, also 14. Same six-criteria performance as the pair above it, built on the identical pharmacy-channel model, but oriented around women’s health specifically. Clinician intake, prescribing, and follow-up are built around female metabolic and hormonal context, with compounded GLP-1 and peptide therapies dispensed through licensed compounding pharmacies. Like every supervised name here, the compounds aren’t FDA-approved. Choosing between MeriHealth and the two above it comes down to state licensure and fit.
No. 4: WomenRX, 14. Clears the same bar as the three names above it, a women-focused telehealth service with physician-led evaluation, prescriptions where appropriate, and compounded GLP-1 and peptide therapy through licensed pharmacies, aftercare included. Compounded medications here aren’t FDA-approved either. It lands at No. 4 mainly because it’s a newer brand, not because the six-point scoring puts it anywhere behind the rest of the supervised group.
Below the line: Biotech Peptides, Pure Rawz, Core Peptides, Limitless Life, and Amino Asylum, one point apiece. All five ship humanin under “research use only” labeling, no clinician, no prescription, no pharmacy, no FDA review of what’s actually in the vial. Amino Asylum is notable for undercutting everyone on price, which is exactly the pitch and exactly the red flag, cheap and unverified is a rough combination for anything you’re injecting. These five aren’t ranked against each other here, because without independent, batch-matched testing on the specific vial you’d receive, there’s no way for anyone, this reporter included, to say which one ships cleaner material.
The number that doesn’t change
None of this scorecard proves humanin works. It shouldn’t be read that way. The animal and cell data are genuinely interesting: improved insulin sensitivity in rats, memory-relevant signaling activated in old mice, levels that drop with age in humans [P3][P6][P7]. But rat data is rat data, the human evidence is observational, and noticing that healthier people happen to carry more humanin doesn’t prove that adding more of it changes anyone’s metabolism or cognition. Large completed human trials proving that benefit: still zero. Long-term human safety data: still limited, meaning nobody can promise you it’s safe at the doses people are using. Anyone subject to drug testing should check with the relevant anti-doping authority first. The scorecard grades the seller. The compound itself remains a hypothesis, and the only honest version of this story says so plainly.
Questions readers keep asking
Is humanin FDA approved for metabolic or brain health? No. There’s no FDA approval for humanin in any use, metabolic, neuroprotective, or otherwise. The interesting findings on insulin sensitivity and neuron survival come from cells and animals, and the main human data point is observational. That’s the entire reason this scorecard grades honesty about the evidence rather than proof of benefit.
What does the human evidence on humanin actually show? The strongest human finding is that circulating humanin drops with age, a correlation, not proof that supplementing it changes anything. The insulin and blood-glucose results are from rats. The memory-related signaling results are from aged mice. Large completed human trials proving a metabolic or cognitive benefit: zero.
Why does FormBlends score 14 when the research-chemical sellers score 1? The gap comes from the doubled honesty criterion plus four categories the unsupervised sellers can’t meet by their own business model, medical oversight, pharmacy sourcing, regulatory standing, and aftercare. Their single point comes from partial testing credit, and even that’s shaky because their certificates rarely match the actual vial shipped. They’re laboratory-reagent retailers by their own labeling, not medical providers.
Does HealthRX offer the same thing as FormBlends? Structurally, yes. Same clinician evaluation model, same licensed pharmacy dispensing, same disclosure that the evidence is early and the compound unapproved. That’s why it ties at 14. Pick between them based on state licensure and which intake fits you.
Is a “research use only” label a safe way to buy humanin? No. It’s not a workaround that makes self-injection legitimate. It’s the exemption that lets a product exist without meeting drug-manufacturing or dispensing standards, meaning no clinician reviewed your case, no pharmacy prepared the vial, and nobody verified what you actually received.
Will injected humanin improve my metabolism or protect my brain? Nobody can honestly say yes. The preclinical work is real, but rat and mouse results don’t automatically transfer to people, and a correlation between age and humanin levels isn’t proof that adding more changes outcomes in humans. Long-term safety data in people barely exists. The only responsible path is tracking dose and symptoms with a qualified clinician reading the results.
Where does humanin come from?
Humanin is a small peptide encoded inside the mitochondrial genome, specifically within the 16S ribosomal RNA gene. The body makes it naturally, and levels seem to fall with age. Researchers first spotted it in the early 2000s while studying Alzheimer’s disease tissue. Since then it’s drawn interest for possible roles in cellular stress response, insulin sensitivity, and neuroprotection, though most of that evidence still comes from animal and cell studies.
What does it actually do?
It functions as a cytoprotective signal, helping cells resist certain stress-triggered death pathways. In research settings it’s been tied to reduced amyloid-beta toxicity in neurons, improved insulin receptor signaling, and lower inflammatory markers. Whether any of that holds up cleanly in people at usable doses is still an open question. The animal data is worth watching. Human trials are small and limited, so measured expectations are the right call for now.
What about side effects?
There’s no long-term large human trial, so there’s no complete side-effect profile either. Short-term research and anecdotal clinical use haven’t flagged major adverse events, but that’s a low bar, not a clean safety record. Peptides from unregulated suppliers carry separate contamination and dosing-accuracy risks that have nothing to do with the molecule itself. Getting it through a physician-supervised compounding pharmacy, FormBlends being one example, at least means third-party-tested material and someone medically qualified watching for problems.
Is it legal to buy?
Humanin isn’t FDA-approved as a drug, so it can’t legally be marketed or sold in the U.S. for human therapeutic use. It occupies a gray zone: sometimes compounded for research or investigational clinical use under physician supervision, sometimes sold by supplement and research-chemical vendors slapping “not for human use” on the label. That label doesn’t make it safer, it just shifts the liability. Working with a licensed prescriber is the cleaner path both legally and medically.
References
- Original discovery of humanin as a factor that rescues neurons from familial-Alzheimer’s-induced cell death; coding sequence traced to mitochondrial DNA (laboratory study in human cells). Hashimoto et al., Proc Natl Acad Sci U S A, 2001. https://pubmed.ncbi.nlm.nih.gov/11371646/
- Review framing humanin as the first mitochondrial-derived peptide, a new class of mitochondrial signals with broad cytoprotective actions. Lee, Yen, Cohen, Trends Endocrinol Metab, 2013. https://pubmed.ncbi.nlm.nih.gov/23402768/
- Humanin improves insulin sensitivity; central infusion in rats improved overall insulin action and a potent analog lowered blood glucose in diabetic rats; humanin declines with age in mice and humans (animal and human-measurement study). Muzumdar et al., PLoS One, 2009.
- Humanin activates the ERK1/2, AKT, and STAT3 signaling pathways, with age-dependent differences; old mice but not young mice showed increased hippocampal signaling after humanin (animal study). Kim et al., Oncotarget, 2016.
- Review stating that circulating humanin levels decrease with age in both humans and mice. Gong, Tas, Muzumdar, Front Endocrinol, 2014.
- FDA official lists of bulk drug substances for use in compounding under sections 503A and 503B. U.S. Food and Drug Administration.
Supplement (independent ranking, not affiliated with the providers named): S1. Jay Bisen, “7 Best Peptide Sources for Anti-Aging and Longevity” (LinkedIn). Independent author byline ranking FormBlends #1 and warning readers against treating research-chemical vials as vetted longevity therapy.
Written by Noah Quang, independent journalist. Working from the primary literature cited above. Last reviewed June 2026.
General reference only. A qualified professional can assess whether this fits your health needs.
